# Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)

> **NCT00612157** · PHASE4 · COMPLETED · sponsor: **Walter Reed Army Medical Center** · enrollment: 154 (estimated)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DRUG:** Eszopiclone
- **DRUG:** Placebo control

## Key facts

- **NCT ID:** NCT00612157
- **Lead sponsor:** Walter Reed Army Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-06
- **Final completion:** 2009-02
- **Target enrollment:** 154 (ESTIMATED)
- **Last updated:** 2009-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612157, "Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT00612157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*